Sonnenberg A, Blum A L
Acta Hepatogastroenterol (Stuttg). 1979 Dec;26(6):469-71.
4-(4-chlor-N-(4-methoxyphenyl)-benzamido)-butanic acid (clanobutin) reduces gastric cell exfoliation at an oral dose of 1800 mg/day. A dose of 900 mg/day had no effect. It may thus exert its benefical effect on ulcer healing.
4-(4-氯-N-(4-甲氧基苯基)-苯甲酰胺基)-丁酸(克拉诺布汀)以每日1800毫克的口服剂量可减少胃细胞脱落。每日900毫克的剂量则无效果。因此,它可能对溃疡愈合产生有益作用。